Renaissance Technologies’s Carisma Therapeutics CARM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$129K Buy
329,286
+75,629
+30% +$29.6K ﹤0.01% 3260
2025
Q1
$78.6K Buy
253,657
+22,300
+10% +$6.91K ﹤0.01% 3228
2024
Q4
$96.9K Buy
231,357
+24,600
+12% +$10.3K ﹤0.01% 3290
2024
Q3
$203K Buy
206,757
+67,397
+48% +$66.2K ﹤0.01% 3122
2024
Q2
$212K Sell
139,360
-86,635
-38% -$132K ﹤0.01% 3026
2024
Q1
$513K Buy
225,995
+12,961
+6% +$29.4K ﹤0.01% 2855
2023
Q4
$624K Buy
213,034
+8,339
+4% +$24.4K ﹤0.01% 2680
2023
Q3
$866K Buy
204,695
+102,935
+101% +$435K ﹤0.01% 2400
2023
Q2
$892K Buy
101,760
+33,465
+49% +$293K ﹤0.01% 2539
2023
Q1
$212K Buy
68,295
+17,347
+34% +$53.8K ﹤0.01% 3252
2022
Q4
$621K Sell
50,948
-1,842
-3% -$22.5K ﹤0.01% 2821
2022
Q3
$449K Buy
52,790
+22,090
+72% +$188K ﹤0.01% 2986
2022
Q2
$498K Buy
30,700
+7,828
+34% +$127K ﹤0.01% 3168
2022
Q1
$276K Buy
+22,872
New +$276K ﹤0.01% 3509
2021
Q4
Sell
-78,484
Closed -$1.25M 3915
2021
Q3
$1.25M Buy
78,484
+15,054
+24% +$239K ﹤0.01% 2430
2021
Q2
$5.86M Sell
63,430
-123,965
-66% -$11.5M 0.01% 1534
2021
Q1
$9.75M Buy
187,395
+41,844
+29% +$2.18M 0.01% 1216
2020
Q4
$3.93M Buy
145,551
+44,705
+44% +$1.21M ﹤0.01% 1736
2020
Q3
$2.82M Buy
100,846
+36,941
+58% +$1.03M ﹤0.01% 1917
2020
Q2
$920K Buy
63,905
+53,494
+514% +$770K ﹤0.01% 2577
2020
Q1
$117K Buy
+10,411
New +$117K ﹤0.01% 3197
2018
Q4
Sell
-700
Closed -$30K 3387
2018
Q3
$30K Sell
700
-801
-53% -$34.3K ﹤0.01% 3306
2018
Q2
$59K Buy
+1,501
New +$59K ﹤0.01% 3179
2016
Q3
Sell
-5,925
Closed -$198K 3335
2016
Q2
$198K Buy
5,925
+300
+5% +$10K ﹤0.01% 3052
2016
Q1
$36K Buy
+5,625
New +$36K ﹤0.01% 3300